QuickView for PDE4B;jsessionid=16BA33D194091596FBEEAE45E78F7A6A;jsessionid=468B4BFDEE6357D96E60304308247E73;jsessionid=8ABAD8E57969277BE736476461A92080;jsessionid=79B972D9795F53A5DEECDFF0703F486C;jsessionid=904E7AD29F91E3321AF6966AB068BBDD;jsessionid=EA72230294EAA0EAF2092095D44F7357;jsessionid=A6171D3325BE69202419065DB3FFD68B (gene)

1. Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic …
2. Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains.
3. Selective Inhibition of PDE4B Reduces Methamphetamine Reinforcement in Two C57BL/6 Substrains.
4. MiR-124-3p targeting PDE4B attenuates LPS-induced ALI through the TLR4/NF-κB signaling pathway.
5. LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activa…

There were no clinical trials for PDE4B;jsessionid=16BA33D194091596FBEEAE45E78F7A6A;jsessionid=468B4BFDEE6357D96E60304308247E73;jsessionid=8ABAD8E57969277BE736476461A92080;jsessionid=79B972D9795F53A5DEECDFF0703F486C;jsessionid=904E7AD29F91E3321AF6966AB068BBDD;jsessionid=EA72230294EAA0EAF2092095D44F7357;jsessionid=A6171D3325BE69202419065DB3FFD68B